Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs).
Diabetes Ther · 2021
Last updated 2026-05-28| Journal | Diabetes Ther, 2021 |
|---|---|
| Citations | 28 |
| Relative citation ratio | 2.09 |
| NIH percentile | 75 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease |
Abstract
This communication provides a contemporary classification of glucagon-like peptide 1 receptor agonists (GLP1RAs) based on indication, route, and frequency of administration, which could support a person-centric approach to treatment choice. It includes all recently developed GLP1RAs as well as those in advanced stages of clinical study. Keeping pace with current trends in pharmacology and metabolic medicine, it attempts to bring clarity and simplicity to a complex spread of information.
Verbatim abstract via PubMed 34268675 ↗